nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AI applications in renal pathology
|
Huo, Yuankai |
|
|
99 |
6 |
p. 1309-1320 |
artikel |
2 |
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas lpr mice with proliferative lupus nephritis predicts low effect size
|
Lei, Yutian |
|
|
99 |
6 |
p. 1331-1341 |
artikel |
3 |
Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
|
Attias, Philippe |
|
|
99 |
6 |
p. 1490-1492 |
artikel |
4 |
APOL1 at 10 years: progress and next steps
|
Freedman, Barry I. |
|
|
99 |
6 |
p. 1296-1302 |
artikel |
5 |
A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass
|
Graham-Brown, Matthew P.M. |
|
|
99 |
6 |
p. 1478-1486 |
artikel |
6 |
A tale of 100 kidney stones
|
Sy-Go, Janina Paula T. |
|
|
99 |
6 |
p. 1502 |
artikel |
7 |
Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period
|
Blosser, Christopher D. |
|
|
99 |
6 |
p. 1430-1438 |
artikel |
8 |
Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes
|
Dujardin, Amaury |
|
|
99 |
6 |
p. 1418-1429 |
artikel |
9 |
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|
Babitt, Jodie L. |
|
|
99 |
6 |
p. 1280-1295 |
artikel |
10 |
Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification
|
Mary, Aurélien |
|
|
99 |
6 |
p. 1382-1391 |
artikel |
11 |
Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation
|
Ramspek, Chava L. |
|
|
99 |
6 |
p. 1459-1469 |
artikel |
12 |
Does a preclinical randomized controlled trial, pRCT, resolve the gap between animal studies and human trials?
|
Nangaku, Masaomi |
|
|
99 |
6 |
p. 1262-1264 |
artikel |
13 |
Editorial Board
|
|
|
|
99 |
6 |
p. A1 |
artikel |
14 |
Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
|
Yanay, Noa Berar |
|
|
99 |
6 |
p. 1496-1498 |
artikel |
15 |
Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy
|
Negrea, Lavinia |
|
|
99 |
6 |
p. 1487 |
artikel |
16 |
Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution
|
Eknoyan, Garabed |
|
|
99 |
6 |
p. 1321-1330 |
artikel |
17 |
Hydroxycobalamin-induced pigmented effluent during dialysis
|
Foley, Edward D. |
|
|
99 |
6 |
p. 1503 |
artikel |
18 |
Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans
|
Zhou, Chao |
|
|
99 |
6 |
p. 1342-1353 |
artikel |
19 |
Hypoxia signaling in renal pericytes—is it safe to activate?
|
Herbek, Savannah |
|
|
99 |
6 |
p. 1267-1269 |
artikel |
20 |
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
|
Ikizler, T. Alp |
|
|
99 |
6 |
p. 1275-1279 |
artikel |
21 |
Inferring causality from observational studies: the role of instrumental variable analysis
|
Fu, Rui |
|
|
99 |
6 |
p. 1303-1308 |
artikel |
22 |
In this issue
|
|
|
|
99 |
6 |
p. 1251 |
artikel |
23 |
Intradialytic exercise improves left ventricular mass in hemodialysis patients
|
Chowdhury, Raad |
|
|
99 |
6 |
p. 1272-1274 |
artikel |
24 |
Intradialytic hypotension: is timing everything?
|
Sohn, Peter |
|
|
99 |
6 |
p. 1269-1272 |
artikel |
25 |
Journal Club
|
|
|
|
99 |
6 |
p. 1252-1254 |
artikel |
26 |
Kidney pericyte hypoxia-inducible factor regulates erythropoiesis but not kidney fibrosis
|
Pan, Szu-Yu |
|
|
99 |
6 |
p. 1354-1368 |
artikel |
27 |
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
|
Clarke, Candice L. |
|
|
99 |
6 |
p. 1470-1477 |
artikel |
28 |
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
|
Benotmane, Ilies |
|
|
99 |
6 |
p. 1498-1500 |
artikel |
29 |
Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife
|
Żurowska, Aleksandra M. |
|
|
99 |
6 |
p. 1451-1458 |
artikel |
30 |
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
|
Torreggiani, Massimo |
|
|
99 |
6 |
p. 1494-1496 |
artikel |
31 |
Outcome of diacylglycerol kinase epsilon–mediated hemolytic uremic syndrome in an infant
|
Koyun, Mustafa |
|
|
99 |
6 |
p. 1500-1501 |
artikel |
32 |
Phosphate meeting cholesterol—consequences for cardiovascular disease in chronic kidney disease?
|
Hénaut, Lucie |
|
|
99 |
6 |
p. 1264-1267 |
artikel |
33 |
Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner
|
Shrestha, Pragyi |
|
|
99 |
6 |
p. 1369-1381 |
artikel |
34 |
SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
|
Anft, Moritz |
|
|
99 |
6 |
p. 1489-1490 |
artikel |
35 |
Searching for the origin of the myofibroblast one cell at a time
|
Fogo, Agnes B. |
|
|
99 |
6 |
p. 1259-1261 |
artikel |
36 |
Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
|
Billany, Roseanne E. |
|
|
99 |
6 |
p. 1492-1494 |
artikel |
37 |
Subscription Information
|
|
|
|
99 |
6 |
p. A4 |
artikel |
38 |
Supportive therapy for cast nephropathy
|
Cancarini, Giovanni |
|
|
99 |
6 |
p. 1501 |
artikel |
39 |
Table of Contents
|
|
|
|
99 |
6 |
p. A5, A7, A9, A11, A13 |
artikel |
40 |
The Case | A 38-year-old man with hydronephrosis
|
Choi, Hong Sang |
|
|
99 |
6 |
p. 1505-1506 |
artikel |
41 |
The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy
|
Stevens, Jacob S. |
|
|
99 |
6 |
p. 1507-1508 |
artikel |
42 |
The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1 RC/RC mouse model of autosomal dominant polycystic kidney disease
|
Arroyo, Jennifer |
|
|
99 |
6 |
p. 1392-1407 |
artikel |
43 |
The time of onset of intradialytic hypotension during a hemodialysis session associates with clinical parameters and mortality
|
Keane, David F. |
|
|
99 |
6 |
p. 1408-1417 |
artikel |
44 |
Updating the International IgA Nephropathy Prediction Tool for use in children
|
Barbour, Sean J. |
|
|
99 |
6 |
p. 1439-1450 |
artikel |
45 |
Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
|
Benotmane, Ilies |
|
|
99 |
6 |
p. 1487-1489 |
artikel |
46 |
Whole exome sequencing of large populations: identification of loss of function alleles and implications for inherited kidney diseases
|
Geraghty, Robert |
|
|
99 |
6 |
p. 1255-1259 |
artikel |